The Association of HHV-6 and the (-308G/A) Promotor with Major Depressive Disorder Patients and Healthy Controls in Thailand
Overview
Authors
Affiliations
Major depressive disorder (MDD) is a silent global health problem that can lead to suicide. MDD development is suggested to result from numerous risk factors, including genetic factors. A precise tool for MDD diagnosis is currently not available. Recently, inflammatory processes have been identified as being strongly involved in MDD development and the reactivation of human herpesvirus type 6 (HHV-6), upregulating cytokines such as TNF-, which are associated with MDD. Therefore, this study aimed to determine the association of HHV-6 with genetic factors, especially mutation, in MDD patients and their relatives compared to healthy controls. The Patient Health Questionnaire (PHQ-9) was used to evaluate MDD status, and 471 oral buccal samples were investigated for HHV-6 infection and viral copy number by qPCR. (-308G/A) gene mutation and the cytokines TNF-α, IL-6, and IL-10 were analyzed by high-resolution melting (HRM) analysis and enzyme-linked immunosorbent assay (ELISA). Whole-exome sequencing of buccal samples was performed to analyze for genetic factors. The results showed significantly higher HHV-6 positivities and viral loads in MDD patients (15/59 (25.67%) and 14,473 ± 16,948 copies/µL DNA) and their relatives (blood relatives 17/36 (47.22%) and 8146 ± 5656 copies/µL DNA); non-blood relatives 7/16 (43.75%) and 20,721 ± 12,458 copies/µL DNA) compared to the healthy population (51/360 (14.17%) and 6303 ± 5791 copies/µL DNA). The (-308G/A) mutation showed no significant difference. Surprisingly, 12/26 (46.15%) participants with the (-308G/A) mutation showed HHV-6 positivities at higher rates than those with wild-type (-308G) (70/267 (26.22%)). HHV-6-positive participants with (-308G/A) showed higher levels of TNF-α, IL-6, and IL-10 than those of negative control. Exome analysis revealed that common mutations in immune genes were associated with depression. Therefore, this study unveiled the novel association of inflammatory gene (-308G/A) mutations with HHV-6 reactivation, which could represent a combined risk factor for MDD. This result could induce further research on MDD development and clinical applications.
Bumrungthai S, Buddhisa S, Duangjit S, Passorn S, Sumala S, Prakobkaew N Biomed Rep. 2024; 21(6):181.
PMID: 39420919 PMC: 11484186. DOI: 10.3892/br.2024.1869.
Bumrungthai S, Duangjit S, Passorn S, Pongpakdeesakul S, Butsri S, Janyakhantikul S Biomed Rep. 2024; 21(4):144.
PMID: 39170756 PMC: 11337157. DOI: 10.3892/br.2024.1832.
Gusev E, Sarapultsev A Int J Mol Sci. 2024; 25(12).
PMID: 38928096 PMC: 11204317. DOI: 10.3390/ijms25126389.
Identification of a strong genetic risk factor for major depressive disorder in the human virome.
Kobayashi N, Shimada K, Ishii A, Osaka R, Nishiyama T, Shigeta M iScience. 2024; 27(3):109203.
PMID: 38414857 PMC: 10897923. DOI: 10.1016/j.isci.2024.109203.